“Detox,” supplements and cleanses: what is supposed to be removed?

“Detox” can mean medically managed care for withdrawal from a particular substance. It can also mean a commercial procedure that claims to “clean” the body or remove addiction itself. The label does not tell you what will actually happen. Risk assessment, observation and treatment of withdrawal complications are medical work. Fasting, an herbal mixture or a laxative advertised as removing “toxins” does not become that treatment because it shares a name.

The US NCCIH describes different “cleanses” and the limits of evidence for their advertised effects. Studies about weight or metabolic measures cannot be relabelled as evidence that a substance use disorder has been treated. Nor does that make every supplement dangerous or every centre dishonest. We first need to know the actual product, procedure, indication and promised result.

With physical adaptation, the body may react to a substance being changed or stopped. That reaction warrants assessment, but physical adaptation, including to a prescribed medicine, does not by itself establish addiction. Treating alcohol or sedative withdrawal as a test of willpower at home can be especially dangerous. The UK NHS alcohol use disorder page explains why abruptly stopping alcohol when dependent may be dangerous and why care is planned with clinicians. An older 2012 WHO recommendation concerns the management of alcohol withdrawal, not instructions for a person to carry out alone; its page labels the evidence for several recommendations as low quality.

Managed withdrawal can be a necessary stage, but it does not erase the circumstances of use, pain, anxiety, housing problems or the need for further care. For opioid use disorder, the US CDC specifically warns against detoxification alone without medication treatment, because return to use and overdose are risks. This concerns opioids in that clinical context. It does not supply one plan for every substance or prove that the same treatment is available everywhere.

A medicine prescribed for an indication and a supplement carrying an advertising claim need different checks. Ask for the exact name and ingredients, their amounts, the intended use, possible interactions and what the person already takes. NCCIH points out that supplements may interact with medicines and cause adverse effects. That is not a verdict on every supplement. A confirmed nutritional deficiency may itself merit professional correction; it does not show that a “cleanse” removes addiction.

The US FDA's supplement FAQ explains that dietary supplements in the United States generally do not receive FDA approval before marketing, although other requirements apply. This is US regulation, not a worldwide registration rule. A quality document or permission to sell also does not, on its own, establish that this very product treats a substance use disorder as advertised.

Imagine a hypothetical offer: “Our seven-day course completely clears traces of the drug and addiction will never return.” It contains at least two claims: one about a physiological measure and another about a person's future. Each needs an appropriate outcome, follow-up period and study population. “Natural” and “proven” reveal neither the method nor the result. The FTC's US health-product advertising guidance calls for suitable substantiation of specific claims. It is not a court finding about this fictional offer.

Useful questions make the conversation concrete. What exactly is in the course? Was the measured outcome comfort, a short-lived change in a test, remaining in treatment, later substance use or harm? Compared with what, for whom, for how long, and who left the study? Can the team recognise a complication, arrange medical care and continue indicated prescriptions? Missing answers do not automatically establish fraud, but they do not oblige anyone to pay or take a health risk for a promise.

A person can tell a clinician or local substance use service: “I have been offered a detox or supplement. I use these substances and medicines and I am worried about withdrawal. Please help me assess the risk and treatment options.” When making contact, ask about consultation language, price, waiting time, age requirements, data handling and who will actually see the person. If the first service cannot see them, another reachable contact is needed; a referral or booking is not yet care received. Perfect abstinence, faith or a complete account of one's life is not a condition for asking.

Do not stop prescribed medicines on your own or attempt a home taper, fast, laxative “cleanse” or self-directed metal chelation as withdrawal care. Threats or violence call for a separate safe channel, not a mandatory joint conversation with the threatening person. If an adult cannot currently care for a child, another capable adult needs to be present and actually take over; a service's phone number is not childcare. A child must not monitor medicines, interpret medical conversations or manage an adult's recovery. Check local rules on consent, confidentiality and access where you live. Ordinary service questions must not delay emergency medical contact when danger is present.

• NCCIH, Detoxes and Cleanses: What You Need To Know — US fact sheet updated March 2025; cleanse claims and risks, not substance use treatment trials.
• FDA, Questions and Answers on Dietary Supplements — US regulatory FAQ; the edition date was not established in the section read; jurisdiction is the United States.
• FTC, Health Products Compliance Guidance — US advertising regulator staff guidance, December 2022; claim substantiation, not a finding against a named seller.
• NCCIH, 5 Tips: What Consumers Need To Know About Dietary Supplements — US consumer advice; page date not established in the section read; supplement interactions and safety.
• NHS, Alcohol use disorder — UK patient page reviewed 24 April 2026; medical assessment of alcohol withdrawal.
• WHO, Management of alcohol withdrawal — 2012 mhGAP recommendation with low-quality evidence specified; clinical management, not home instructions.
• CDC, Treating Opioid Use Disorder — US clinical page dated 9 April 2024; limits of detoxification alone in OUD.
• NHS, Sudden confusion (delirium) — UK page reviewed 28 May 2024; immediate help for new sudden confusion.
• NHS, Poisoning — UK page reviewed 12 June 2025; immediate contact on suspicion before symptoms.

Only identified sections of these pages were read, not all linked research, individual products or local law. Sources are summarised briefly in original wording; no full pages, tables, forms, scales or protected material were reproduced. Clinical, native Thai, legal and human acceptance have not taken place; the article does not replace an individual assessment.

detox, dietary supplements, cleanses, alcohol, opioids, withdrawal, health advertising, evidence, safety, addiction treatment, consent, access to care

Andrey Zarinsh — author and founder of United Wisdom. He explores inner transformation, the unity of traditions, intercultural dialogue, and contemporary spiritual discipline. Instagram: @andrey.zarinsh.

Maria Evilkut — co-author of United Wisdom. Alongside her research, she seeks to test these ideas in practice and observe how principles of unity and mutual understanding work in real life between people and cultures. Instagram: @ilkutki.

15 October 2026. English version.